NEXT Houston — Houston, Texas

NEXT Houston is a clinical research site located in Houston, Texas, United States 77054.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

NEXT Houston has participated in 7 clinical trials with 7 currently active.

Therapeutic areas: Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer, NSCLC.

Sponsors: Incendia Therapeutics, Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD., SystImmune Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Houston?

NEXT Houston has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Houston conducted?

NEXT Houston has 7 clinical trials on record, with 7 currently active. Their work covers Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer, NSCLC.

Is NEXT Houston accredited by Crixeo Health?

Yes — NEXT Houston holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about NEXT Houston?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.